Germline EGFR mutations in lung cancer (Review)
- Authors:
- Minghui Liu
- Xiaoyu Niu
- Hongyu Liu
- Jun Chen
-
Affiliations: Department of Lung Cancer Surgery, Tianjin Medical University General Hospital, Heping, Tianjin 300052, P.R. China, Tianjin Key Laboratory of Lung Cancer Metastasis and Tumor Microenvironment, Tianjin Lung Cancer Institute, Tianjin Medical University General Hospital, Heping, Tianjin 300052, P.R. China - Published online on: May 16, 2023 https://doi.org/10.3892/ol.2023.13868
- Article Number: 282
-
Copyright: © Liu et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
This article is mentioned in:
Abstract
 |
|
Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA and Jemal A: Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 68:394–424. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Kanwal M, Ding XJ, Song X, Zhou GB and Cao Y: MUC16 overexpression induced by gene mutations promotes lung cancer cell growth and invasion. Oncotarget. 9:12226–12239. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Subramanian J, Velcheti V, Gao F and Govindan R: Presentation and stage-specific outcomes of lifelong never-smokers with non-small cell lung cancer (NSCLC). J Thorac Oncol. 2:827–830. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Arnheim N and Calabrese P: Understanding what determines the frequency and pattern of human germline mutations. Nat Rev Genet. 10:478–488. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Tang XN, Shigematsu H, Bekele BN, Roth JA, Minna JD, Hong WK, Gazdar AF and Wistuba II: EGFR tyrosine kinase domain mutations are detected in histologically normal respiratory epithelium in lung cancer patients. Cancer Res. 65:7568–7572. 2005. View Article : Google Scholar : PubMed/NCBI | |
|
Arteaga CL: EGF receptor mutations in lung cancer: From humans to mice and maybe back to humans. Cancer Cell. 9:421–423. 2006. View Article : Google Scholar : PubMed/NCBI | |
|
Yu HA, Arcila ME, Hellmann MD, Kris MG, Ladanyi M and Riely GJ: Poor response to erlotinib in patients with tumors containing baseline EGFR T790M mutations found by routine clinical molecular testing. Ann Oncol. 25:423–428. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Oxnard GR, Miller VA, Robson ME, Azzoli CG, Pao W, Ladanyi M and Arcila ME: Screening for germline EGFR T790M mutations through lung cancer genotyping. J Thorac Oncol. 7:1049–1052. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Gazdar A, Robinson L, Oliver D, Xing C, Travis WD, Soh J, Toyooka S, Watumull L, Xie Y, Kernstine K and Schiller JH: Hereditary lung cancer syndrome targets never smokers with germline EGFR gene T790M mutations. J Thorac Oncol. 9:456–463. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Girard N, Lou E, Azzoli CG, Reddy R, Robson M, Harlan M, Orlow I, Yatabe Y, Nafa K, Ladanyi M, et al: Analysis of genetic variants in never-smokers with lung cancer facilitated by an Internet-based blood collection protocol: A preliminary report. Clin Cancer Res. 16:755–763. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Vikis H, Sato M, James M, Wang D, Wang Y, Wang M, Jia D, Liu Y, Bailey-Wilson JE, Amos CI, et al: EGFR-T790M is a rare lung cancer susceptibility allele with enhanced kinase activity. Cancer Res. 67:4665–4670. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Amos CI, Gorlov IP, Dong Q, Wu X, Zhang H, Lu EY, Scheet P, Greisinger AJ, Mills GB and Spitz MR: Nicotinic acetylcholine receptor region on chromosome 15q25 and lung cancer risk among African Americans: A case-control study. J Natl Cancer Inst. 102:1199–1205. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Yi D, Xu L, Luo J, You X, Huang T, Zi Y, Li X, Wang R, Zhong Z, Tang X, et al: Germline TP53 and MSH6 mutations implicated in sporadic triple-negative breast cancer (TNBC): A preliminary study. Hum Genomics. 13:42019. View Article : Google Scholar : PubMed/NCBI | |
|
Lu S, Yu Y, Li Z, Yu R, Wu X, Bao H, Ding Y, Shao YW and Jian H: EGFR and ERBB2 germline mutations in Chinese lung cancer patients and their roles in genetic susceptibility to cancer. J Thorac Oncol. 14:732–736. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Mäkinen N, Zhou M, Bemus M, Nevin J, Nag A, Chen R, Colson YL, Thorner AR, Oxnard GR, Meyerson M and Sholl LM: Genomic evolution in a patient with lung adenocarcinoma with a germline EGFR T790M mutation. JTO Clin Res Rep. 2:1001462021.PubMed/NCBI | |
|
Bell DW, Gore I, Okimoto RA, Godin-Heymann N, Sordella R, Mulloy R, Sharma SV, Brannigan BW, Mohapatra G, Settleman J and Haber DA: Inherited susceptibility to lung cancer may be associated with the T790M drug resistance mutation in EGFR. Nat Genet. 37:1315–1316. 2005. View Article : Google Scholar : PubMed/NCBI | |
|
Prudkin L, Tang X and Wistuba II: Germ-line and somatic presentations of the EGFR T790M mutation in lung cancer. J Thorac Oncol. 4:139–141. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Tibaldi C, Giovannetti E, Vasile E, Boldrini L, Gallegos-Ruiz MI, Bernardini I, Incensati R, Danesi R, Cappuzzo F, Peters GJ and Fontanini G: Inherited germline T790M mutation and somatic epidermal growth factor receptor mutations in non-small cell lung cancer patients. J Thorac Oncol. 6:395–396. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Shih JY, Gow CH, Yu CJ, Yang CH, Chang YL, Tsai MF, Hsu YC, Chen KY, Su WP and Yang PC: Epidermal growth factor receptor mutations in needle biopsy/aspiration samples predict response to gefitinib therapy and survival of patients with advanced nonsmall cell lung cancer. Int J Cancer. 118:963–969. 2006. View Article : Google Scholar : PubMed/NCBI | |
|
Ikeda K, Nomori H, Mori T, Sasaki J and Kobayashi T: Novel germline mutation: EGFR V843I in patient with multiple lung adenocarcinomas and family members with lung cancer. Ann Thorac Surg. 85:1430–1432. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Ohtsuka K, Ohnishi H, Kurai D, Matsushima S, Morishita Y, Shinonaga M, Goto H and Watanabe T: Familial lung adenocarcinoma caused by the EGFR V843I germ-line mutation. J Clin Oncol. 29:e191–e192. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Matsushima S, Ohtsuka K, Ohnishi H, Fujiwara M, Nakamura H, Morii T, Kishino T, Goto H and Watanabe T: V843I, a lung cancer predisposing EGFR mutation, is responsible for resistance to EGFR tyrosine kinase inhibitors. J Thorac Oncol. 9:1377–1384. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Demierre N, Zoete V, Michielin O, Stauffer E, Zimmermann DR, Betticher DC and Peters S: A dramatic lung cancer course in a patient with a rare EGFR germline mutation exon 21 V843I: Is EGFR TKI resistance predictable? Lung Cancer. 80:81–84. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Prim N, Legrain M, Guerin E, Mennecier B, Weingertner N, Voegeli AC, Guenot D, Maugard CM, Quoix AE and Beau-Faller M: Germ-line exon 21 EGFR mutations, V843I and P848L, in nonsmall cell lung cancer patients. Eur Respir Rev. 23:390–392. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Song H, Chen Y, Yan Z, Sun G and Shi Z: Response to osimertinib in a NSCLC patient harboring EGFR V843I germ-line mutation. Lung Cancer. 150:247–248. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
van Noesel J, van der Ven WH, van Os TAM, Kunst PWA, Weegenaar J, Reinten RJA, Kancha RK, Duyster J and van Noesel CJ: Activating germline R776H mutation in the epidermal growth factor receptor associated with lung cancer with squamous differentiation. J Clin Oncol. 31:e161–e164. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Guo T, Zhu L, Li W, Lin R, Ding Y, Kang Q, Shao L, Li C and Pan X: Two cases of non-small cell lung cancer patients with somatic or germline EGFR R776H mutation. Lung Cancer. 161:94–97. 2021. View Article : Google Scholar : PubMed/NCBI | |
|
de Gunst MM, Gallegos-Ruiz MI, Giaccone G and Rodriguez JA: Functional analysis of cancer-associated EGFR mutants using a cellular assay with YFP-tagged EGFR intracellular domain. Mol Cancer. 6:562007. View Article : Google Scholar : PubMed/NCBI | |
|
Lin X, Peng M, Chen Q, Yuan M, Chen R, Deng H, Deng J, Liu O, Weng Y, Chen M and Zhou C: Identification of the unique clinical and genetic features of chinese lung cancer patients with EGFR germline mutations in a large-scale retrospective study. Front Oncol. 11:7741562021. View Article : Google Scholar : PubMed/NCBI | |
|
Borràs E, Jurado I, Hernan I, Gamundi MJ, Dias M, Martí I, Mañé B, Arcusa A, Agúndez JA, Blanca M and Carballo M: Clinical pharmacogenomic testing of KRAS, BRAF and EGFR mutations by high resolution melting analysis and ultra-deep pyrosequencing. BMC Cancer. 11:4062011. View Article : Google Scholar : PubMed/NCBI | |
|
Han B, Zhou X, Zhang RX, Zang WF, Chen ZY, Song HD, Wan HY and Zheng CX: Mutations of the epidermal growth factor receptor gene in NSCLC patients. Oncol Lett. 2:1233–1237. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Klughammer B, Brugger W, Cappuzzo F, Ciuleanu T, Mok T, Reck M, Tan EH, Delmar P, Klingelschmitt G, Yin AY, et al: Examining treatment outcomes with erlotinib in patients with advanced non-small cell lung cancer whose tumors harbor uncommon EGFR mutations. J Thorac Oncol. 11:545–555. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Sarcar B, Gimbrone NT, Wright G, Remsing Rix LL, Gordian ER, Rix U, Chiappori AA, Reuther GW, Santiago-Cardona PG, Muñoz-Antonia T and Cress WD: Characterization of epidermal growth factor receptor (EGFR) P848L, an unusual EGFR variant present in lung cancer patients, in a murine Ba/F3 model. FEBS Open Bio. 9:1689–1704. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Yang J, Li H, Li B, Li W, Guo Q, Hu L, Song Z and Zhou B: Profiling oncogenic germline mutations in unselected chinese lung cancer patients. Front Oncol. 11:6475982021. View Article : Google Scholar : PubMed/NCBI | |
|
Shukuya T and Takahashi K: Germline mutations in lung cancer. Respir Investig. 57:201–206. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Nachman MW and Crowell SL: Estimate of the mutation rate per nucleotide in humans. Genetics. 156:297–304. 2000. View Article : Google Scholar : PubMed/NCBI | |
|
Lu C, Xie M, Wendl MC, Wang J, McLellan MD, Leiserson MD, Huang KL, Wyczalkowski MA, Jayasinghe R, Banerjee T, et al: Patterns and functional implications of rare germline variants across 12 cancer types. Nat Commun. 6:100862015. View Article : Google Scholar : PubMed/NCBI | |
|
Huang KL, Mashl RJ, Wu Y, Ritter DI, Wang J, Oh C, Paczkowska M, Reynolds S, Wyczalkowski MA, Oak N, et al: Pathogenic germline variants in 10,389 adult cancers. Cell. 173:355–370.e14. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Wang Y, McKay JD, Rafnar T, Wang Z, Timofeeva MN, Broderick P, Zong X, Laplana M, Wei Y, Han Y, et al: Rare variants of large effect in BRCA2 and CHEK2 affect risk of lung cancer. Nat Genet. 46:736–741. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Peng W, Li B, Li J, Chang L, Bai J, Yi Y, Chen R, Zhang Y, Chen C, Pu X, et al: Clinical and genomic features of Chinese lung cancer patients with germline mutations. Nat Commun. 13:12682022. View Article : Google Scholar : PubMed/NCBI | |
|
Choi SK, Yoon SR, Calabrese P and Arnheim N: A germ-line-selective advantage rather than an increased mutation rate can explain some unexpectedly common human disease mutations. Proc Natl Acad Sci USA. 105:10143–10148. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Tiemann-Boege I, Navidi W, Grewal R, Cohn D, Eskenazi B, Wyrobek AJ and Arnheim N: The observed human sperm mutation frequency cannot explain the achondroplasia paternal age effect. Proc Natl Acad Sci USA. 99:14952–14957. 2002. View Article : Google Scholar : PubMed/NCBI | |
|
Kan SH, Elanko N, Johnson D, Cornejo-Roldan L, Cook J, Reich EW, Tomkins S, Verloes A, Twigg SR, Rannan-Eliya S, et al: Genomic screening of fibroblast growth-factor receptor 2 reveals a wide spectrum of mutations in patients with syndromic craniosynostosis. Am J Hum Genet. 70:472–486. 2002. View Article : Google Scholar : PubMed/NCBI | |
|
Qin J, Calabrese P, Tiemann-Boege I, Shinde DN, Yoon SR, Gelfand D, Bauer K and Arnheim N: The molecular anatomy of spontaneous germline mutations in human testes. PLoS Biol. 5:e2242007. View Article : Google Scholar : PubMed/NCBI | |
|
Crow JF: Age and sex effects on human mutation rates: An old problem with new complexities. J Radiat Res. 47 (Suppl B):B75–B82. 2006. View Article : Google Scholar : PubMed/NCBI | |
|
Malter HE, Iber JC, Willemsen R, de Graaff E, Tarleton JC, Leisti J, Warren ST and Oostra BA: Characterization of the full fragile X syndrome mutation in fetal gametes. Nat Genet. 15:165–169. 1997. View Article : Google Scholar : PubMed/NCBI | |
|
Moutou C, Vincent MC, Biancalana V and Mandel JL: Transition from premutation to full mutation in fragile X syndrome is likely to be prezygotic. Hum Mol Genet. 6:971–979. 1997. View Article : Google Scholar : PubMed/NCBI | |
|
Silveira I, Alonso I, Guimarães L, Mendonça P, Santos C, Maciel P, Fidalgo De Matos JM, Costa M, Barbot C, Tuna A, et al: High germinal instability of the (CTG)n at the SCA8 locus of both expanded and normal alleles. Am J Hum Genet. 66:830–840. 2000. View Article : Google Scholar : PubMed/NCBI | |
|
Delatycki MB, Paris D, Gardner RJ, Forshaw K, Nicholson GA, Nassif N, Williamson R and Forrest SM: Sperm DNA analysis in a Friedreich ataxia premutation carrier suggests both meiotic and mitotic expansion in the FRDA gene. J Med Genet. 35:713–716. 1998. View Article : Google Scholar : PubMed/NCBI | |
|
De Temmerman N, Sermon K, Seneca S, De Rycke M, Hilven P, Lissens W, Van Steirteghem A and Liebaers I: Intergenerational instability of the expanded CTG repeat in the DMPK gene: Studies in human gametes and preimplantation embryos. Am J Hum Genet. 75:325–329. 2004. View Article : Google Scholar : PubMed/NCBI | |
|
Moseley ML, Schut LJ, Bird TD, Koob MD, Day JW and Ranum LP: SCA8 CTG repeat: En masse contractions in sperm and intergenerational sequence changes may play a role in reduced penetrance. Hum Mol Genet. 9:2125–1230. 2000. View Article : Google Scholar : PubMed/NCBI | |
|
De Michele G, Cavalcanti F, Criscuolo C, Pianese L, Monticelli A, Filla A and Cocozza S: Parental gender, age at birth and expansion length influence GAA repeat intergenerational instability in the X25 gene: Pedigree studies and analysis of sperm from patients with Friedreich's ataxia. Hum Mol Genet. 7:1901–1906. 1998. View Article : Google Scholar : PubMed/NCBI | |
|
Hultén MA, Patel SD, Westgren M, Papadogiannakis N, Jonsson AM, Jonasson J and Iwarsson E: On the paternal origin of trisomy 21 Down syndrome. Mol Cytogenet. 3:42010. View Article : Google Scholar : PubMed/NCBI | |
|
Li N, Liu C, Xiong L, Huang D and Jiang Y: Pedigree analysis of the EGFR p.V1010M germline mutation in a family with a family history of non-small-cell lung cancer. Ann Transl Med. 10:1542022. View Article : Google Scholar : PubMed/NCBI | |
|
van der Leest C, Wagner A, Pedrosa RM, Aerts JG, Dinjens WNM and Dubbink HJ: Novel EGFR V834L germline mutation associated with familial lung adenocarcinoma. JCO Precis Oncol. 2:PO.17.00266. 2018.PubMed/NCBI | |
|
Trabelsi Grati O, Zemoura L, Nhy C, Daniel C, Melaabi S, Callens C, Gauthier Villars M, Bièche I and Girard N: Long response to immune checkpoint inhibitors in metastatic NSCLC despite EGFR germline mutation. A case report. Lung Cancer. 174:186–187. 2022. View Article : Google Scholar : PubMed/NCBI |
